Latest News
Astronomical Prices of Some Cancer Drugs Hit Vulnerable Patients Hard
60 Minutes reported last Sunday on the high price of cancer drugs in the U.S. Lesley Stahl’s piece shed light on the fact that Medicare has to pay the price determined by the drug companies, since under current law, Medicare is prohibited from negotiating the prices. The report noted that some cancer patients have gone into bankruptcy in an effort to save their lives. Dr. Leonard Saltz, chief of gastrointestinal oncology at Memorial Sloan Kettering, noted that a patient could easily be paying $250,000 for two drugs, “just to get started.”..Read More
This posting is presented for informational purposes only and does not represent legal or financial guidance. Any opinions or interpretations presented are either those of the original author or, in the case of articles authored by the AMAC Foundation, are the opinions of AMAC Foundation staff, originally trained and accredited by the National Social Security Association (NSSA) and certified via the AMAC Foundation. Any links included in the article are valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the links’ validity. NSSA and the AMAC Foundation and its staff are not affiliated with or endorsed by the Social Security Administration or any other governmental entity. To submit a question, visit our website (https://amacfoundation.org/services/) or email us at ssadvisor@amacfoundation.org. Because we are a non-profit organization, there is no charge for these services.